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 Springer Science+Business Media New York 2014
This fourth special electroporation-based technologies
and treatments issue of the Journal of Membrane Biology
contains reports on recent developments in the field of
electroporation by participants in the 7th International
Workshop and Postgraduate Course on electroporation-
based technologies and treatments (EBTT 2013) held in
Ljubljana, November 17–23, 2013. The 65 participants
included faculty members, invited lecturers, special
guests, and young scientists, and students from 16
countries. In addition to lectures on the fundamentals,
this year’s sessions included talks on microbial inacti-
vation by pulsed electric fields, modeling of intracellular
electroporation, electroporation in food processing, and
electrotransfer-facilitated DNA vaccination. One of the
strengths and attractions of this workshop-course is the
practical training exercises offered each afternoon.
Organized and led by colleagues from the Laboratory of
Biocybernetics of the Faculty of Electrical Engineering
at the University of Ljubljana and by visiting research-
ers, these afternoon laboratory sessions provide a unique
opportunity for hands-on experience guided by experts,
with activities ranging from fluorescence microscopy to
electrical characterization of artificial membranes to
molecular dynamics simulations. The school is now an
established and unique platform for the acquisition of
theoretical and practical knowledge of electroporation
mechanisms and applications.
The workshop and postgraduate course was conducted
within the scope of the European Associated Laboratory on
Pulsed Electric Fields Applications in Biology and Medicine
(LEA EBAM) and co-organized by COST TD1104 Action
(http://www.electroporation.net/). COST—European Coop-
eration in Science and Technology is the oldest intergov-
ernmental framework aimed at facilitating the collaboration
and networking of scientists and researchers at the European
level established in 1971 (http://www.cost.eu).
The peer-reviewed selection of articles in this issue
provides a cross-section of the ongoing electroporation-
related research being carried out by participants at the
Ljubljana meeting. We are grateful to the contributors for
their efforts in presenting their recent results, which will
challenge readers, whether new or old in the field, to
evaluate assumptions and consider new ideas, and we are
especially grateful to our scientific colleagues who
reviewed the manuscripts.
Finally we acknowledge the indispensable support of the
agencies, societies, and companies who sponsor the school,
in particular the Slovenian Research Agency, the Centre
National de la Recherche Scientifique (CNRS), and the
Bioelectrochemical Society, which has sponsored the
school from its very beginning, and also IGEA (Italy),
Mikro ? Polo (Slovenia), Iskra Medical (Slovenia), C3 M
(Slovenia), BIA Separations (Slovenia), LTFE (Slovenia),
Profector (Ireland), and the University of Bielefeld (Ger-
many), who made it possible to increase student partici-
pation through reduced fees and lodging expenses.
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COST—European Cooperation in Science and Tech-
nology is an intergovernmental framework aimed at facil-
itating the collaboration and networking of scientists and
researchers at European level. It was established in 1971 by
19 member countries and currently includes 35 member
countries across Europe, and Israel as a cooperating state.
COST funds pan-European, bottom-up networks of
scientists and researchers across all science and technology
fields. These networks, called ‘COST Actions’, promote
international coordination of nationally-funded research.
By fostering the networking of researchers at an inter-
national level, COST enables break-through scientific
developments leading to new concepts and products,
thereby contributing to strengthening Europe’s research
and innovation capacities.
COST’s mission focuses in particular on:
• Building capacity by connecting high quality scientific
communities throughout Europe and worldwide.
• Providing networking opportunities for early career
investigators.
• Increasing the impact of research on policy makers,
regulatory bodies and national decision makers as well
as the private sector.
Through its inclusiveness, COST supports the integra-
tion of research communities, leverages national research
investments, and addresses issues of global relevance.
Every year thousands of European scientists benefit from
being involved in COST Actions, allowing the pooling of
national research funding to achieve common goals.
As a precursor of advanced multidisciplinary research,
COST anticipates and complements the activities of EU
Framework Programmes, constituting a ‘‘bridge’’ toward the
scientific communities of emerging countries. In particular,
COST actions are also open to participation by non-European
scientists coming from neighbor countries (for example Alba-
nia, Algeria, Armenia, Azerbaijan, Belarus, Egypt, Georgia,
Jordan, Lebanon, Libya, Moldova, Montenegro, Morocco, the
Palestinian Authority, Russia, Syria, Tunisia, and Ukraine) and
from a number of international partner countries.
COST’s budget for networking activities has tradition-
ally been provided by successive EU RTD Framework
Programmes. COST is currently executed by the European
Science Foundation (ESF) through the COST Office on a
mandate by the European Commission, and the framework
is governed by a Committee of Senior Officials (CSO)
representing all its 35 member countries.
More information about COST is available at www.cost.
eu.
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